(Q39043505)

English

Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells

scientific article published on 13 December 2013

Statements

Epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A inhibits the growth of cholangiocarcinoma cells (English)
Shigeki Nakagawa
Hiromitsu Hayashi
Daisuke Hashimoto

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit